Trial Profile

A multicenter, observational study for reactivation of hepatitis B virus by means of serial HBV-DNA monitoring during and just after systemic chemotherapy containing rituximab plus steroid for malignant lymphoma (C-SHOT 0802)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 26 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Pirarubicin; Prednisolone; Procarbazine; Vincristine
Indications B-cell lymphoma; Non-Hodgkin's lymphoma
Focus Adverse reactions

24 Oct 2017 Results of retrospective analysis assessing clinical significance of HBsAg assay to diagnosing HBV reactivation by using data from this study presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases
09 Jul 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
12 Aug 2011 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com